Total Payments
$13,581
2024 Payments
$2,212
Companies
11
Transactions
24
Medicare Patients
738
Medicare Billing
$87,300
Payment Breakdown by Category
Consulting$11,925 (87.8%)
Food & Beverage$1,334 (9.8%)
Education$322.21 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,925 | 3 | 87.8% |
| Food and Beverage | $1,334 | 15 | 9.8% |
| Education | $322.21 | 6 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ADC Therapeutics America, Inc. | $11,926 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $525.00 | 1 | $0 (2024) |
| Seagen Inc. | $316.40 | 3 | $0 (2023) |
| Incyte Corporation | $158.99 | 2 | $0 (2018) |
| BeiGene USA, Inc. | $147.62 | 2 | $0 (2024) |
| Mallinckrodt LLC | $125.00 | 1 | $0 (2017) |
| Genentech USA, Inc. | $123.25 | 1 | $0 (2017) |
| Seattle Genetics, Inc. | $99.13 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $68.22 | 3 | $0 (2023) |
| Genmab U.S., Inc. | $47.74 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,212 | 8 | ADC Therapeutics America, Inc. ($1,514) |
| 2023 | $10,678 | 7 | ADC Therapeutics America, Inc. ($10,413) |
| 2022 | $35.84 | 1 | E.R. Squibb & Sons, L.L.C. ($35.84) |
| 2021 | $11.07 | 1 | E.R. Squibb & Sons, L.L.C. ($11.07) |
| 2020 | $95.00 | 1 | Seagen Inc. ($95.00) |
| 2019 | $43.33 | 1 | Foundation Medicine, Inc. ($43.33) |
| 2018 | $99.00 | 1 | Incyte Corporation ($99.00) |
| 2017 | $407.37 | 4 | Mallinckrodt LLC ($125.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $78.00 | General |
| Category: Oncology | ||||||
| 12/06/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $37.79 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 06/05/2024 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 04/05/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Oncology | ||||||
| 04/03/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $162.83 | General |
| 04/02/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $112.93 | General |
| 04/02/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $69.62 | General |
| Category: Oncology | ||||||
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Education | In-kind items and services | $21.31 | General |
| Category: Hematology | ||||||
| 12/10/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $142.71 | General |
| 12/10/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: Oncology | ||||||
| 08/01/2023 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,200.00 | General |
| 05/09/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $102.04 | General |
| Category: Oncology | ||||||
| 03/21/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $70.23 | General |
| 12/09/2022 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Education | In-kind items and services | $35.84 | General |
| Category: Oncology | ||||||
| 10/26/2021 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $11.07 | General |
| Category: Hematology | ||||||
| 02/03/2020 | Seagen Inc. | — | Education | In-kind items and services | $95.00 | General |
| 04/11/2019 | Foundation Medicine, Inc. | FOUNDATIONACT (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Food and Beverage | Cash or cash equivalent | $43.33 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2018 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 10/11/2017 | Incyte Corporation | — | Education | Cash or cash equivalent | $59.99 | General |
| 05/10/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $123.25 | General |
| Category: BioOncology | ||||||
| 03/07/2017 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $99.13 | General |
| Category: Not Applicable | ||||||
| 02/15/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 189 | 303 | $84,319 | $23,378 |
| 2022 | 8 | 186 | 319 | $80,168 | $21,212 |
| 2021 | 6 | 171 | 255 | $75,937 | $21,399 |
| 2020 | 7 | 192 | 300 | $76,762 | $21,311 |
Total Patients
738
Total Services
1,177
Medicare Billing
$87,300
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 102 | $31,504 | $7,380 | 23.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 39 | $9,444 | $3,732 | 39.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 44 | $7,574 | $2,671 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 18 | $5,814 | $1,851 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 36 | $9,580 | $1,772 | 18.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $5,719 | $1,673 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 20 | $6,152 | $1,567 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $5,045 | $1,496 | 29.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 19 | $3,487 | $1,237 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 100 | $30,300 | $7,772 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 37 | $11,211 | $2,779 | 24.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 44 | $7,392 | $2,503 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 46 | $11,960 | $2,303 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,103 | $1,312 | 32.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 17 | $2,601 | $1,292 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 23 | $5,980 | $1,260 | 21.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $3,648 | $962.42 | 26.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 18 | $1,620 | $566.96 | 35.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $1,353 | $461.29 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 87 | $26,361 | $6,828 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 21 | 38 | $11,514 | $2,911 | 25.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 23 | $8,579 | $2,704 | 31.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $6,286 | $2,303 | 36.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 38 | $6,209 | $2,240 | 36.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 13 | 16 | $5,968 | $1,884 | 31.6% |
About Dr. Thomas Ollila, M.D
Dr. Thomas Ollila, M.D is a Internal Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1184984049.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Ollila, M.D has received a total of $13,581 in payments from pharmaceutical and medical device companies, with $2,212 received in 2024. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($11,925).
As a Medicare-enrolled provider, Ollila has provided services to 738 Medicare beneficiaries, totaling 1,177 services with total Medicare billing of $87,300. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Providence, RI
- Active Since 05/24/2012
- Last Updated 06/21/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184984049
Products in Payments
- CALQUENCE (Drug) $525.00
- ADCETRIS (Biological) $320.53
- BRUKINSA (Drug) $147.62
- OFIRMEV (Drug) $125.00
- TECENTRIQ (Biological) $123.25
- Epkinly (Drug) $47.74
- FOUNDATIONACT (Device) $43.33
- SPRYCEL (Drug) $35.84
- REBLOZYL (Biological) $21.31
- Pomalyst (Drug) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Providence
Randall Ingham, M.d, M.D
Internal Medicine — Payments: $154,470
Internal Medicine $154,470
Farah Moustafa, Md, MD
Internal Medicine — Payments: $50,984
Internal Medicine $50,984
Monica Dhakar, M.d, M.D
Internal Medicine — Payments: $47,405
Internal Medicine $47,405
Hajra Awwab, Md, MD
Internal Medicine — Payments: $41,418
Internal Medicine $41,418
Richard Ruggieri, M.d, M.D
Internal Medicine — Payments: $36,352
Internal Medicine $36,352
Dr. Peter Barth, M.d, M.D
Internal Medicine — Payments: $29,192
Internal Medicine $29,192